首页 > 最新文献

Spine Journal最新文献

英文 中文
Re-evaluation of categorial outcomes using common clinically relevant improvement thresholds following bilateral L2 medial branch restorative neurostimulation versus sham. 双侧L2内侧支恢复性神经刺激与假手术后使用常见临床相关改善阈值重新评估分类结果。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-13 DOI: 10.1016/j.spinee.2025.12.002
Matthew Smuck, Dylan Lukes, Byron Schneider, David J Kennedy, Allen S Chen, Zachary L McCormick
<p><strong>Background context: </strong>When chronic low back pain (cLBP) persists after conservative management, there are limited treatment options. Increasingly, researchers and clinicians are defining distinct phenotypes within the cLBP population to develop and provide more targeted and effective interventions. One such phenotype involves people with mechanical low back pain and impaired motor control, identified by physical exam or MRI evidence of multifidus dysfunction. An implantable neurostimulation device that delivers an electrical stimulation to the L2 medial branch has been recently FDA-approved, with initially encouraging preliminary results. The pivotal trial demonstrated statistically-significant benefits over sham treatment in all secondary outcomes but not the primary outcome at the 120-day primary endpoint. However, recently published 1- and 5-year studies have shown better outcomes compared to optimal medical management.</p><p><strong>Purpose: </strong>It was our purpose to expand the comparison of clinical outcomes between this neurostimulation treatment and sham by re-evaluating the data from the aforementioned pivotal trial using common clinically-relevant thresholds of treatment success that were not included in the pivotal trial's uncommon composite definition of treatment success or in its analysis of secondary outcomes for Oswestry Disability Index (ODI) and EQ-5D that compared mean improvements instead of categorical responder rates.</p><p><strong>Study design/setting: </strong>Posthoc reanalysis of previously published data from a prospective, randomized, double-blind, multicenter sham-controlled clinical trial.</p><p><strong>Patient sample: </strong>From 26 centers, 204 participants age 46.53±9.38 years (range 22-71) and 53.9% (110/204) female were recruited with mechanical cLBP despite physical therapy and medical management, and a positive prone instability test on physical exam.</p><p><strong>Outcome measures: </strong>Participants completed several patient-reported outcomes at baseline and at the primary endpoint of 120 days following activation of the implanted stimulator or sham, including: visual analog scale, ODI, EQ-5D, and subject global impression of change.</p><p><strong>Methods: </strong>Using a complete-case analysis, we compared differences between the neurostimulation treatment group and the sham-control group. Demographics are expressed using descriptive statistics. Patient-reported outcomes are compared between groups with a categorical analysis, setting responder thresholds at commonly used benchmarks and established minimum clinically important change (MCIC) thresholds. Statistical significance is determined by a two-sided p-value from Fisher's exact test with significance set at p<.05. Potential conflicts of interest directly related to this manuscript include research funding to support MS (level e) and DL (level b). The sponsor funded the original sham-controlled trial and funded this reanalysi
背景背景:当慢性腰痛(cLBP)在保守治疗后持续存在时,治疗选择有限。越来越多的研究人员和临床医生在cLBP人群中定义不同的表型,以开发和提供更有针对性和有效的干预措施。其中一种表型包括机械性腰痛和运动控制受损的人,通过身体检查或多裂肌功能障碍的MRI证据确定。最近fda批准了一种植入式神经刺激装置,该装置可向L2内侧分支提供电刺激,初步结果令人鼓舞。关键试验显示,在120天的主要终点,在所有次要结局中,与假药治疗相比,统计学上有显著的益处,但在主要结局中没有。然而,最近发表的1年和5年研究表明,与最佳医疗管理相比,结果更好。目的:我们的目的是通过重新评估上述关键试验的数据,扩大神经刺激治疗和假手术之间的临床结果的比较,使用常见的临床相关治疗成功阈值,这些阈值未包括在关键试验不常见的治疗成功复合定义中,也未包括在ODI和EQ-5D的次要结局分析中,比较的是平均改善而不是分类反应率。研究设计/设置:对一项前瞻性、随机、双盲、多中心假对照临床试验先前发表的数据进行事后再分析。患者样本:来自26个中心的204名参与者,年龄46.53±9.38岁(22-71岁),53.9%(110/204)为女性,尽管进行了物理治疗和医疗管理,但仍患有机械性cLBP,体检中倾向不稳定试验呈阳性。结果测量:在植入刺激器或假体激活后120天的基线和主要终点,参与者完成了几个患者报告的结果,包括:VAS、ODI、EQ-5D和受试者总体变化印象(SGIC)。方法:采用全病例分析方法,比较神经刺激治疗组与假对照组的差异。人口统计数据是用描述性统计来表示的。通过分类分析比较两组患者报告的结果,在常用基准上设置应答者阈值,并建立最小临床重要变化(MCIC)阈值。统计显著性由Fisher精确检验的双侧p值确定,显著性集为结果:3名患者(2名活跃患者,1名假手术患者)失去随访,留下201名参与者进行完整病例分析。从基线到120天的主要终点,在ODI的MCIC阈值上观察到支持积极治疗的统计学显著差异:≥15点改善(59% vs 40.6%, p=0.0111)和≥30%改善(65.0% vs 47.5%, p=0.0156);EQ-5D的MCIC:改善≥0.15 (57.0% vs 36.0%, p=0.0045);SGIC为“更好”或更高(54.0% vs 33.7%; p=0.0045)。疼痛结果是混合的;尽管平均变化倾向于积极治疗(-3.3±2.7 vs -2.4±2.9;p=0.0209),但两组的分类有效率无显著差异(MCIC≥2点VAS改善和≥50%改善)。结论:将双侧L2内侧分支恢复性神经刺激与假手术在120天的主要终点进行比较,采用常见的临床相关治疗成功阈值,这项由赞助商资助的假手术对照关键试验的再分析显示,在残疾、生活质量和患者满意度方面的治疗具有统计学意义和临床意义,而疼痛的变化则有不同的结果。
{"title":"Re-evaluation of categorial outcomes using common clinically relevant improvement thresholds following bilateral L2 medial branch restorative neurostimulation versus sham.","authors":"Matthew Smuck, Dylan Lukes, Byron Schneider, David J Kennedy, Allen S Chen, Zachary L McCormick","doi":"10.1016/j.spinee.2025.12.002","DOIUrl":"10.1016/j.spinee.2025.12.002","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background context: &lt;/strong&gt;When chronic low back pain (cLBP) persists after conservative management, there are limited treatment options. Increasingly, researchers and clinicians are defining distinct phenotypes within the cLBP population to develop and provide more targeted and effective interventions. One such phenotype involves people with mechanical low back pain and impaired motor control, identified by physical exam or MRI evidence of multifidus dysfunction. An implantable neurostimulation device that delivers an electrical stimulation to the L2 medial branch has been recently FDA-approved, with initially encouraging preliminary results. The pivotal trial demonstrated statistically-significant benefits over sham treatment in all secondary outcomes but not the primary outcome at the 120-day primary endpoint. However, recently published 1- and 5-year studies have shown better outcomes compared to optimal medical management.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;It was our purpose to expand the comparison of clinical outcomes between this neurostimulation treatment and sham by re-evaluating the data from the aforementioned pivotal trial using common clinically-relevant thresholds of treatment success that were not included in the pivotal trial's uncommon composite definition of treatment success or in its analysis of secondary outcomes for Oswestry Disability Index (ODI) and EQ-5D that compared mean improvements instead of categorical responder rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design/setting: &lt;/strong&gt;Posthoc reanalysis of previously published data from a prospective, randomized, double-blind, multicenter sham-controlled clinical trial.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient sample: &lt;/strong&gt;From 26 centers, 204 participants age 46.53±9.38 years (range 22-71) and 53.9% (110/204) female were recruited with mechanical cLBP despite physical therapy and medical management, and a positive prone instability test on physical exam.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;Participants completed several patient-reported outcomes at baseline and at the primary endpoint of 120 days following activation of the implanted stimulator or sham, including: visual analog scale, ODI, EQ-5D, and subject global impression of change.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Using a complete-case analysis, we compared differences between the neurostimulation treatment group and the sham-control group. Demographics are expressed using descriptive statistics. Patient-reported outcomes are compared between groups with a categorical analysis, setting responder thresholds at commonly used benchmarks and established minimum clinically important change (MCIC) thresholds. Statistical significance is determined by a two-sided p-value from Fisher's exact test with significance set at p&lt;.05. Potential conflicts of interest directly related to this manuscript include research funding to support MS (level e) and DL (level b). The sponsor funded the original sham-controlled trial and funded this reanalysi","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative weight loss is not beneficial in obese patients undergoing cervical or lumbar fusion-a national cohort study of 57,961 patients. 术前体重减轻对接受颈椎或腰椎融合的肥胖患者无益——一项57,961例患者的国家队列研究。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-13 DOI: 10.1016/j.spinee.2025.12.008
Muhammad Talal Ibrahim, James Caid Kirven, Diego Martinez Castaneda, Phillip Glivar, Venkat Kavuri, Varun Kumar Singh, Elizabeth Yu
<p><strong>Background context: </strong>Morbid obesity is a known risk factor for worse outcomes after spinal fusion. Preoperative weight loss (WL) is routinely advocated for obese spinal fusion candidates based on the assumption that postoperative risk in patients with lower body mass index (BMI), after recent WL, is equivalent to that in weight-stable patients. However, this assumption has not been directly tested in the literature.</p><p><strong>Purpose: </strong>To compare obese patients who lost ≥5% of body weight within 2 years prior to undergoing cervical or lumbar fusion with obese patients who maintained a stable weight prior to surgery.</p><p><strong>Design: </strong>Retrospective cohort study with propensity score matching.</p><p><strong>Patient sample: </strong>Epic Cosmos was used to identify obese patients (BMI 30-50 kg/m<sup>2</sup>) undergoing cervical or lumbar fusion between 2017 and 2023. Patients were divided into two cohorts: (1) WL: patients with 5% to 30% body WL within 2 years preoperatively, (2) no WL (NoWL): controls with stable weight. Patients with pathological WL were excluded.</p><p><strong>Outcome measures: </strong>At 90 days, length of stay, healthcare utilization (HCU), severe adverse events (SAEs), and minor adverse events (MAEs) were assessed. At the 2-year follow-up, surgical failure (SF) was assessed.</p><p><strong>Methods: </strong>Cohorts were matched on demographics, preweight-loss BMI, comorbidities, diagnoses, and operative factors using propensity score matching. Analyses for cervical and lumbar fusions were run independently. Multivariable linear or logistic regression was used to determine the odds ratio of outcomes, adjusting for age, sex, race, preweight-loss BMI, comorbidities, diagnoses, and operative factors. Sensitivity analysis was conducted by excluding myelopathic patients and additionally adjusting the regression models for BMI at surgery.</p><p><strong>Results: </strong>After matching, the cervical fusion groups consisted of 10,201 patients per cohort, with a mean age of 59.4 years, 52.6% females, and 75.3% white patients. The WL cohort had higher rates of HCU (11.5% vs. 8.8%), SAEs (10.7% vs. 9.0%), MAEs (14.0% vs. 10.9%), and SF (11.6% vs. 9.7%). The lumbar fusion groups consisted of 10,755 patients per cohort, with a mean age of 62.4 years, 56.1% female, and 77.7% white patients. The WL cohort also had higher rates of HCU (12.2% vs. 11.6%), SAEs (11.0% vs. 10.0%), MAEs (24.9% vs. 22.8%), and SF (13.8% vs. 12.9%). In multivariable regression analysis, the cervical fusion WL cohort had higher odds of HCU (adjusted odds ratio [aOR]: 1.28, p<.001), MAEs (aOR: 1.26, p<.001), and SF (aOR: 1.20, p<.001), as well as increased length of stay (adjusted beta-coefficient [aβ]: 0.53, p<.001) compared to cervical fusion NoWL cohort. Statistical significance was no longer observed after removing myelopathic patients. In the lumbar fusion cohorts, there were no statistical differences in the outcomes in
背景:病态肥胖是脊柱融合术后不良预后的已知危险因素。术前减重通常被提倡用于肥胖脊柱融合术候选者,这是基于一个假设,即体重指数(BMI)较低的患者在近期减重后的术后风险与体重稳定的患者相当。然而,这一假设尚未在文献中得到直接检验。目的:比较颈椎或腰椎融合术前两年内体重减轻≥5%的肥胖患者与术前体重保持稳定的肥胖患者。设计:倾向评分匹配的回顾性队列研究。患者样本:EPIC COSMOS用于识别2017年至2023年间接受颈椎或腰椎融合术的肥胖患者(BMI 30-50 kg/m2)。患者分为两组:(a)体重减轻(WL):术前两年内体重减轻5-30%的患者;(b)体重未减轻(NoWL):体重稳定的对照组。排除病理性体重减轻的患者。结果测量:在90天时,评估住院时间(LOS)、医疗保健利用率(HCU)、严重不良事件(SAEs)和轻微不良事件(MAEs)。在两年的随访中,评估手术失败(SF)。方法:采用倾向评分匹配,根据人口统计学、减肥前BMI、合并症、诊断和手术因素对队列进行匹配。对颈椎和腰椎融合进行独立分析。采用多变量线性或逻辑回归来确定结果的优势比,调整年龄、性别、种族、减肥前BMI、合并症、诊断和手术因素。通过排除脊髓病患者并调整手术时BMI的回归模型进行敏感性分析。结果:匹配后,颈椎融合组每队列10,201例患者,平均年龄59.4岁,女性占52.6%,白人占75.3%。WL组的HCU发生率(11.5%比8.8%)、SAEs发生率(10.7%比9.0%)、MAEs发生率(14.0%比10.9%)和手术失败发生率(11.6%比9.7%)较高。腰椎融合术组每组10,755例患者,平均年龄为62.4岁,56.1%为女性,77.7%为白人。WL组的HCU(12.2%比11.6%)、SAEs(11.0%比10.0%)、MAEs(24.9%比22.8%)和手术失败(13.8%比12.9%)的发生率也更高。在多变量回归分析中,颈椎融合术WL队列与颈椎融合术NoWL队列相比,HCU(校正优势比(aOR): 1.28, p < 0.001)、MAEs (aOR: 1.26, p < 0.001)和手术失败(aOR: 1.20, p < 0.001)的几率更高,LOS(校正β系数(aβ): 0.53, p < 0.001)也更高。在切除脊髓病患者后,不再观察到统计学意义。在腰椎融合队列中,WL和NoWL队列的所有测量结果均无统计学差异。结论:在肥胖患者中,通过近期减肥来降低BMI并不能获得与体重稳定的较低BMI相同的益处,并且可能增加脊柱融合术后一些并发症的发生率。肌肉量的减少和营养的缺乏也许可以解释为什么在减肥后立即从低BMI中得不到好处。在获得更多数据之前,这些患者的康复前和营养优化可能是合理的。
{"title":"Preoperative weight loss is not beneficial in obese patients undergoing cervical or lumbar fusion-a national cohort study of 57,961 patients.","authors":"Muhammad Talal Ibrahim, James Caid Kirven, Diego Martinez Castaneda, Phillip Glivar, Venkat Kavuri, Varun Kumar Singh, Elizabeth Yu","doi":"10.1016/j.spinee.2025.12.008","DOIUrl":"10.1016/j.spinee.2025.12.008","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background context: &lt;/strong&gt;Morbid obesity is a known risk factor for worse outcomes after spinal fusion. Preoperative weight loss (WL) is routinely advocated for obese spinal fusion candidates based on the assumption that postoperative risk in patients with lower body mass index (BMI), after recent WL, is equivalent to that in weight-stable patients. However, this assumption has not been directly tested in the literature.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;To compare obese patients who lost ≥5% of body weight within 2 years prior to undergoing cervical or lumbar fusion with obese patients who maintained a stable weight prior to surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;Retrospective cohort study with propensity score matching.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient sample: &lt;/strong&gt;Epic Cosmos was used to identify obese patients (BMI 30-50 kg/m&lt;sup&gt;2&lt;/sup&gt;) undergoing cervical or lumbar fusion between 2017 and 2023. Patients were divided into two cohorts: (1) WL: patients with 5% to 30% body WL within 2 years preoperatively, (2) no WL (NoWL): controls with stable weight. Patients with pathological WL were excluded.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;At 90 days, length of stay, healthcare utilization (HCU), severe adverse events (SAEs), and minor adverse events (MAEs) were assessed. At the 2-year follow-up, surgical failure (SF) was assessed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Cohorts were matched on demographics, preweight-loss BMI, comorbidities, diagnoses, and operative factors using propensity score matching. Analyses for cervical and lumbar fusions were run independently. Multivariable linear or logistic regression was used to determine the odds ratio of outcomes, adjusting for age, sex, race, preweight-loss BMI, comorbidities, diagnoses, and operative factors. Sensitivity analysis was conducted by excluding myelopathic patients and additionally adjusting the regression models for BMI at surgery.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;After matching, the cervical fusion groups consisted of 10,201 patients per cohort, with a mean age of 59.4 years, 52.6% females, and 75.3% white patients. The WL cohort had higher rates of HCU (11.5% vs. 8.8%), SAEs (10.7% vs. 9.0%), MAEs (14.0% vs. 10.9%), and SF (11.6% vs. 9.7%). The lumbar fusion groups consisted of 10,755 patients per cohort, with a mean age of 62.4 years, 56.1% female, and 77.7% white patients. The WL cohort also had higher rates of HCU (12.2% vs. 11.6%), SAEs (11.0% vs. 10.0%), MAEs (24.9% vs. 22.8%), and SF (13.8% vs. 12.9%). In multivariable regression analysis, the cervical fusion WL cohort had higher odds of HCU (adjusted odds ratio [aOR]: 1.28, p&lt;.001), MAEs (aOR: 1.26, p&lt;.001), and SF (aOR: 1.20, p&lt;.001), as well as increased length of stay (adjusted beta-coefficient [aβ]: 0.53, p&lt;.001) compared to cervical fusion NoWL cohort. Statistical significance was no longer observed after removing myelopathic patients. In the lumbar fusion cohorts, there were no statistical differences in the outcomes in","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting oxidative stress with amobarbital to prevent intervertebral disc degeneration: part II. Rabbit disc herniation model. 用阿莫巴比妥靶向氧化应激预防椎间盘退变:第二部分。兔椎间盘突出模型。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-13 DOI: 10.1016/j.spinee.2025.12.003
Venkateswaran Ganesh, Douglas C Fredericks, Mitchell C Coleman, Emily B Petersen, Youssef W Naguib, Jordon D Turner, Jaison Marks, James A Martin, Aliasger K Salem, Tae-Hong Lim, Dongrim Seol

Background: Evidence that oxidative stress contributes to the progression of post-traumatic intervertebral disc degeneration suggests targeting oxidant metabolism in disc cells as a strategy to mitigate degeneration in injured discs. We previously identified amobarbital, a drug that suppresses mitochondrial activity in a cell culture model with the chemical induction of oxidative stress, as a promising candidate for this purpose.

Purpose: The objective of this study was to investigate the preventive effects of amobarbital on the progression of disc degeneration using a rabbit disc herniation model.

Study design/setting: The effects of amobarbital on the prevention of disc degeneration were evaluated in both ex vivo and in vivo herniated discs.

Methods: Spine motion segments or animals were randomly assigned for intact control, vehicle control (hydrogel only), and amobarbital. Disc herniation was initiated by puncturing the annulus fibrosus with a needle, and amobarbital was delivered to the nucleus pulposus (NP) in a Pluronic F-127/hyaluronic acid hydrogel. A modified histological classification was applied to evaluate for degenerative cellular and matrix changes in both the annulus fibrosus and NP. Additionally, immunohistochemical staining for apoptosis and oxidative stress response, and radiography for disc height index were examined in the ex vivo and in vivo models, respectively.

Results: Amobarbital injection allowed uniform distribution in the whole NP and showed sustained release for 3 to 4 days. In an organ culture model, amobarbital treatment after a discal injury prohibited morphologic changes of notochordal cells, structural changes of extracellular matrix, endplate chondrocyte migration, and cell apoptosis compared with the vehicle control. Similarly, the preventive effects of amobarbital on disc degeneration were confirmed in an animal study, especially at 2 weeks, with maintained disc height.

Conclusions: In summary, amobarbital injection loaded in F127/hyaluronic acid hydrogel reduced cellular and structural degenerative changes against herniated discal injuries. Therefore, amobarbital has great potential for treating degenerative disc degeneration.

Clinical significance: Amobarbital encapsulated in hydrogel in this model allowed for effective local delivery into the NP and sustained release of amobarbital, which is promising for potential clinical application. Delivering amobarbital in NP cells may be a therapeutic option to retard intervertebral disc degeneration.

背景:有证据表明氧化应激有助于创伤后椎间盘退变的进展,这表明靶向椎间盘细胞的氧化代谢是减轻损伤椎间盘退变的一种策略。我们之前确定了阿莫巴比妥,一种在细胞培养模型中抑制线粒体活性的药物,具有氧化应激的化学诱导作用,作为这一目的的有希望的候选者。目的:本研究的目的是通过兔椎间盘突出模型研究阿莫巴比妥对椎间盘退变进展的预防作用。研究设计/设置:在离体和体内椎间盘突出中评估阿巴比妥对椎间盘退变的预防作用。方法:脊椎运动节段或动物随机分配为完整对照组、载体对照组(仅水凝胶)和阿莫巴比妥组。用针穿刺纤维环引发椎间盘突出,并用Pluronic®F-127/透明质酸(HA)水凝胶将阿莫巴比妥输送到髓核。一种改良的组织学分类被应用于评估纤维环和髓核的退行性细胞和基质变化。此外,在离体和体内模型中分别检测细胞凋亡和氧化应激反应的免疫组织化学染色和椎间盘高度指数的x线摄影。结果:阿莫巴比妥注射液在整个髓核内分布均匀,缓释时间3 ~ 4天。在器官培养模型中,与对照相比,椎间盘损伤后阿莫巴比妥治疗可抑制脊索细胞形态学改变、细胞外基质结构改变、终板软骨细胞迁移和细胞凋亡。同样,在动物实验中证实了阿莫巴比妥对椎间盘退变的预防作用,特别是在维持椎间盘高度的情况下2周。结论:总之,在F127/HA水凝胶中加载阿莫巴比妥注射液可减少椎间盘突出损伤的细胞和结构退行性改变。因此,阿莫巴比妥治疗退行性椎间盘退变具有很大的潜力。临床意义:在该模型中,阿莫巴比妥包被水凝胶,可有效局部给药至髓核,且阿莫巴比妥可持续释放,具有潜在的临床应用前景。在髓核细胞内递送阿巴比妥可能是延缓椎间盘退变的一种治疗选择。
{"title":"Targeting oxidative stress with amobarbital to prevent intervertebral disc degeneration: part II. Rabbit disc herniation model.","authors":"Venkateswaran Ganesh, Douglas C Fredericks, Mitchell C Coleman, Emily B Petersen, Youssef W Naguib, Jordon D Turner, Jaison Marks, James A Martin, Aliasger K Salem, Tae-Hong Lim, Dongrim Seol","doi":"10.1016/j.spinee.2025.12.003","DOIUrl":"10.1016/j.spinee.2025.12.003","url":null,"abstract":"<p><strong>Background: </strong>Evidence that oxidative stress contributes to the progression of post-traumatic intervertebral disc degeneration suggests targeting oxidant metabolism in disc cells as a strategy to mitigate degeneration in injured discs. We previously identified amobarbital, a drug that suppresses mitochondrial activity in a cell culture model with the chemical induction of oxidative stress, as a promising candidate for this purpose.</p><p><strong>Purpose: </strong>The objective of this study was to investigate the preventive effects of amobarbital on the progression of disc degeneration using a rabbit disc herniation model.</p><p><strong>Study design/setting: </strong>The effects of amobarbital on the prevention of disc degeneration were evaluated in both ex vivo and in vivo herniated discs.</p><p><strong>Methods: </strong>Spine motion segments or animals were randomly assigned for intact control, vehicle control (hydrogel only), and amobarbital. Disc herniation was initiated by puncturing the annulus fibrosus with a needle, and amobarbital was delivered to the nucleus pulposus (NP) in a Pluronic F-127/hyaluronic acid hydrogel. A modified histological classification was applied to evaluate for degenerative cellular and matrix changes in both the annulus fibrosus and NP. Additionally, immunohistochemical staining for apoptosis and oxidative stress response, and radiography for disc height index were examined in the ex vivo and in vivo models, respectively.</p><p><strong>Results: </strong>Amobarbital injection allowed uniform distribution in the whole NP and showed sustained release for 3 to 4 days. In an organ culture model, amobarbital treatment after a discal injury prohibited morphologic changes of notochordal cells, structural changes of extracellular matrix, endplate chondrocyte migration, and cell apoptosis compared with the vehicle control. Similarly, the preventive effects of amobarbital on disc degeneration were confirmed in an animal study, especially at 2 weeks, with maintained disc height.</p><p><strong>Conclusions: </strong>In summary, amobarbital injection loaded in F127/hyaluronic acid hydrogel reduced cellular and structural degenerative changes against herniated discal injuries. Therefore, amobarbital has great potential for treating degenerative disc degeneration.</p><p><strong>Clinical significance: </strong>Amobarbital encapsulated in hydrogel in this model allowed for effective local delivery into the NP and sustained release of amobarbital, which is promising for potential clinical application. Delivering amobarbital in NP cells may be a therapeutic option to retard intervertebral disc degeneration.</p>","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the association between insulin resistance and diffuse idiopathic skeletal hyperostosis: a cross-sectional observational study. 探讨胰岛素抵抗与弥漫性特发性骨骼增生之间的关系:一项横断面观察研究。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-13 DOI: 10.1016/j.spinee.2025.12.007
Yu Li, Kairo Wada, Kanichiro Wada, Takaaki Nakano, Gentaro Kumagai, Sho Kaneko, Kazushige Koyama, Sunao Tanaka, Yasuyuki Ishibashi
<p><strong>Background context: </strong>Diffuse idiopathic skeletal hyperostosis (DISH) is a disorder characterized by the calcification and ossification of ligaments and soft tissues, especially ossification of the anterior longitudinal ligament, resulting in the formation of "bridging" osteophytes extending over multiple contiguous segments. The precise etiology of DISH remains unclear; however, metabolic disorders such as diabetes mellitus and hyperlipidemia may be associated with its development. Insulin resistance (IR), a critical component of metabolic syndrome, not only contributes to the dysregulation of blood glucose homeostasis but also influences bone metabolism disorders.</p><p><strong>Purpose: </strong>Considering the association between DISH and metabolic disturbances, we aimed to investigate the relationship between IR and DISH.</p><p><strong>Study design: </strong>Cross-sectional, observational study.</p><p><strong>Patient sample: </strong>This study was conducted using data from the XXX. After screening, a total of 522 patients (206 males, 316 females) were included in the study cohort (mean age: 62.04±10.68 years).</p><p><strong>Outcome measures: </strong>The primary outcome measure was the prevalence of DISH, which was diagnosed using the modified Resnick's criteria based on prior studies. The secondary outcome measure was IR, which was quantified using the Homeostatic Model Assessment of IR (HOMA-IR), with the 75th percentile (1.52) used as the cut-off value.</p><p><strong>Methods: </strong>Logistic regression and receiver operating curve analyses were performed between HOMA-IR and the visceral fat area to verify whether the 75th percentile of HOMA-IR could be used as a cut-off for defining IR. Subsequently, χ² tests and logistic regression analyses were conducted to evaluate the association between HOMA-IR and DISH. Covariates included waist circumference, blood pressure, lipid profiles, fasting glucose levels adjusted for International Diabetes Federation metabolic syndrome criteria, and age. The robustness of the study findings was assessed using log-transformed HOMA-IR and internal validation.</p><p><strong>Results: </strong>Of the 522 participants, 40 were diagnosed with DISH. Higher HOMA-IR (≥1.52, 75th percentile) strongly correlated with higher visceral fat area and significantly higher prevalence of DISH (15.1% vs. 5.1%; p<.001). IR was significantly associated with DISH (odds ratio: 3.17; p=.000478). In adjusted models, the HOMA-IR effect was attenuated, whereas systolic blood pressure and waist circumference remained robustly associated. No significant relationship was found between the HOMA-IR and early-phase DISH.</p><p><strong>Conclusions: </strong>In this sample, higher HOMA-IR was associated with DISH; however, the association attenuated after adjustment for metabolic syndrome components, suggesting that IR is consistent with shared pathways with central obesity and blood pressure rather than demonstrating an i
背景背景:弥漫性特发性骨骼肥厚症(DISH)是一种以韧带和软组织钙化和骨化为特征的疾病,尤其是前纵韧带骨化,导致“桥接”骨赘的形成,延伸到多个连续的节段。DISH的确切病因尚不清楚;然而,代谢紊乱如糖尿病和高脂血症可能与其发展有关。胰岛素抵抗是代谢综合征的重要组成部分,不仅会导致血糖稳态失调,还会影响骨代谢紊乱。目的:考虑到DISH与代谢紊乱之间的关系,我们旨在探讨胰岛素抵抗与DISH的关系。研究设计:横断面观察性研究。患者样本:本研究使用的数据来自XXX。经筛选,共纳入522例患者(男性206例,女性316例),平均年龄:62.04±10.68岁。结果测量:主要结果测量是DISH的患病率,根据先前的研究使用修改的Resnick标准进行诊断。次要结局指标是胰岛素抵抗,使用胰岛素抵抗稳态模型评估(HOMA-IR)进行量化,以第75百分位(1.52)作为截止值。方法:对HOMA-IR和内脏脂肪面积(VFA)进行Logistic回归和受试者工作曲线分析,验证HOMA-IR的第75百分位是否可以作为定义胰岛素抵抗的截止值。随后进行χ 2检验和logistic回归分析,评价HOMA-IR与DISH的相关性。协变量包括腰围、血压、血脂、根据国际糖尿病联合会代谢综合征标准调整的空腹血糖水平和年龄。研究结果的稳健性评估使用对数转换HOMA-IR和内部验证。结果:在522名参与者中,40名被诊断为DISH。较高的HOMA-IR(≥1.52,第75百分位)与较高的VFA和显著较高的DISH患病率密切相关(15.1% vs. 5.1%)。结论:在本样本中,较高的HOMA-IR与DISH相关,然而,在调整代谢综合征成分后,这种关联减弱,这表明胰岛素抵抗与中心性肥胖和血压有共同的途径,而不是胰岛素抵抗的独立影响。
{"title":"Exploring the association between insulin resistance and diffuse idiopathic skeletal hyperostosis: a cross-sectional observational study.","authors":"Yu Li, Kairo Wada, Kanichiro Wada, Takaaki Nakano, Gentaro Kumagai, Sho Kaneko, Kazushige Koyama, Sunao Tanaka, Yasuyuki Ishibashi","doi":"10.1016/j.spinee.2025.12.007","DOIUrl":"10.1016/j.spinee.2025.12.007","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background context: &lt;/strong&gt;Diffuse idiopathic skeletal hyperostosis (DISH) is a disorder characterized by the calcification and ossification of ligaments and soft tissues, especially ossification of the anterior longitudinal ligament, resulting in the formation of \"bridging\" osteophytes extending over multiple contiguous segments. The precise etiology of DISH remains unclear; however, metabolic disorders such as diabetes mellitus and hyperlipidemia may be associated with its development. Insulin resistance (IR), a critical component of metabolic syndrome, not only contributes to the dysregulation of blood glucose homeostasis but also influences bone metabolism disorders.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;Considering the association between DISH and metabolic disturbances, we aimed to investigate the relationship between IR and DISH.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design: &lt;/strong&gt;Cross-sectional, observational study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient sample: &lt;/strong&gt;This study was conducted using data from the XXX. After screening, a total of 522 patients (206 males, 316 females) were included in the study cohort (mean age: 62.04±10.68 years).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;The primary outcome measure was the prevalence of DISH, which was diagnosed using the modified Resnick's criteria based on prior studies. The secondary outcome measure was IR, which was quantified using the Homeostatic Model Assessment of IR (HOMA-IR), with the 75th percentile (1.52) used as the cut-off value.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Logistic regression and receiver operating curve analyses were performed between HOMA-IR and the visceral fat area to verify whether the 75th percentile of HOMA-IR could be used as a cut-off for defining IR. Subsequently, χ² tests and logistic regression analyses were conducted to evaluate the association between HOMA-IR and DISH. Covariates included waist circumference, blood pressure, lipid profiles, fasting glucose levels adjusted for International Diabetes Federation metabolic syndrome criteria, and age. The robustness of the study findings was assessed using log-transformed HOMA-IR and internal validation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Of the 522 participants, 40 were diagnosed with DISH. Higher HOMA-IR (≥1.52, 75th percentile) strongly correlated with higher visceral fat area and significantly higher prevalence of DISH (15.1% vs. 5.1%; p&lt;.001). IR was significantly associated with DISH (odds ratio: 3.17; p=.000478). In adjusted models, the HOMA-IR effect was attenuated, whereas systolic blood pressure and waist circumference remained robustly associated. No significant relationship was found between the HOMA-IR and early-phase DISH.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;In this sample, higher HOMA-IR was associated with DISH; however, the association attenuated after adjustment for metabolic syndrome components, suggesting that IR is consistent with shared pathways with central obesity and blood pressure rather than demonstrating an i","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is endoscopic spine surgery? an introduction to a special issue. 什么是内窥镜脊柱手术?特刊简介。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-12 DOI: 10.1016/j.spinee.2025.12.009
Charla R Fischer
{"title":"What is endoscopic spine surgery? an introduction to a special issue.","authors":"Charla R Fischer","doi":"10.1016/j.spinee.2025.12.009","DOIUrl":"10.1016/j.spinee.2025.12.009","url":null,"abstract":"","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145758270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presidential address 2025. 2025年总统演讲
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-11 DOI: 10.1016/j.spinee.2025.12.001
D Scott Kreiner
{"title":"Presidential address 2025.","authors":"D Scott Kreiner","doi":"10.1016/j.spinee.2025.12.001","DOIUrl":"10.1016/j.spinee.2025.12.001","url":null,"abstract":"","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145752365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to letter to the Editor regarding “Tri-cortical pedicle screw fixation in the most cranial instrumented segment to prevent proximal junctional kyphosis” 关于“三皮质椎弓根螺钉固定在大部分颅骨固定节段预防近端关节后凸”致编辑的信的回复
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-09 DOI: 10.1016/j.spinee.2025.09.001
Zhen Liu MD , Ziyang Tang PhD , Jie Li PhD , Zongshan Hu MD , Xiaodong Qin MD , Benlong Shi MD , Saihu Mao MD , Yong Qiu MD , Zezhang Zhu MD
{"title":"Response to letter to the Editor regarding “Tri-cortical pedicle screw fixation in the most cranial instrumented segment to prevent proximal junctional kyphosis”","authors":"Zhen Liu MD ,&nbsp;Ziyang Tang PhD ,&nbsp;Jie Li PhD ,&nbsp;Zongshan Hu MD ,&nbsp;Xiaodong Qin MD ,&nbsp;Benlong Shi MD ,&nbsp;Saihu Mao MD ,&nbsp;Yong Qiu MD ,&nbsp;Zezhang Zhu MD","doi":"10.1016/j.spinee.2025.09.001","DOIUrl":"10.1016/j.spinee.2025.09.001","url":null,"abstract":"","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":"26 1","pages":"Pages 217-218"},"PeriodicalIF":4.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145705731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor regarding “Tri-cortical pedicle screw fixation in the most cranial instrumented segment to prevent proximal junctional kyphosis” by Liu et al 关于Liu等人“三皮质椎弓根螺钉固定在大部分颅骨固定节段以预防近端关节后凸”的致编辑信
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-12-09 DOI: 10.1016/j.spinee.2025.08.339
Joshua Mathew BS, Mitchell Ng MD, Jonathan Dalton MD, Yasmine Eichbaum BS, Yulia Lee BS, Alexander R. Vaccaro MD, PhD, MBA
{"title":"Letter to the Editor regarding “Tri-cortical pedicle screw fixation in the most cranial instrumented segment to prevent proximal junctional kyphosis” by Liu et al","authors":"Joshua Mathew BS,&nbsp;Mitchell Ng MD,&nbsp;Jonathan Dalton MD,&nbsp;Yasmine Eichbaum BS,&nbsp;Yulia Lee BS,&nbsp;Alexander R. Vaccaro MD, PhD, MBA","doi":"10.1016/j.spinee.2025.08.339","DOIUrl":"10.1016/j.spinee.2025.08.339","url":null,"abstract":"","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":"26 1","pages":"Pages 215-216"},"PeriodicalIF":4.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145705617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Integrating a randomized controlled trial with a parallel observational cohort study in cervical spine surgery insights from the foraminotomy ACDF cost-effectiveness trial (FACET)” [Spine J 25 (2025) 2014–2025] “从椎间孔切开ACDF成本-效果试验(FACET)中整合随机对照试验与平行观察队列研究的颈椎手术见解”的更正[脊柱杂志]25(2025)2014-2025]。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-22 DOI: 10.1016/j.spinee.2025.10.034
Nádia F. Simões de Souza MD , Anne E.H. Broekema MD, PhD , Remko Soer PhD , Katalin Tamási PhD , Antoinette D.I. van Asselt PhD , Michiel F. Reneman PhD , J. Marc C. van Dijk MD, PhD , Jos M.A. Kuijlen MD, PhD , FACET Investigator group
{"title":"Corrigendum to “Integrating a randomized controlled trial with a parallel observational cohort study in cervical spine surgery insights from the foraminotomy ACDF cost-effectiveness trial (FACET)” [Spine J 25 (2025) 2014–2025]","authors":"Nádia F. Simões de Souza MD ,&nbsp;Anne E.H. Broekema MD, PhD ,&nbsp;Remko Soer PhD ,&nbsp;Katalin Tamási PhD ,&nbsp;Antoinette D.I. van Asselt PhD ,&nbsp;Michiel F. Reneman PhD ,&nbsp;J. Marc C. van Dijk MD, PhD ,&nbsp;Jos M.A. Kuijlen MD, PhD ,&nbsp;FACET Investigator group","doi":"10.1016/j.spinee.2025.10.034","DOIUrl":"10.1016/j.spinee.2025.10.034","url":null,"abstract":"","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":"26 2","pages":"Pages 434-435"},"PeriodicalIF":4.7,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145589932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fulfillment of patient expectations after surgery for degenerative cervical myelopathy. A retrospective analysis of prospectively collected data from the multicenter Canadian Surgical Spine Registry (CSORN). 满足退行性颈椎病术后患者的期望。回顾性分析来自多中心加拿大外科脊柱登记处(CSORN)前瞻性收集的数据。
IF 4.7 1区 医学 Q1 CLINICAL NEUROLOGY Pub Date : 2025-11-14 DOI: 10.1016/j.spinee.2025.11.001
Julien Francisco Zaldivar-Jolissaint, Nathan Evaniew, Nicolas Dea, W Bradley Jacobs, Jérome Paquet, Jefferson R Wilson, Hamilton Hall, Supriya Singh, Michael H Weber, Andrew Nataraj, Najmedden Attabib, David W Cadotte, Y Raja Rampersaud, Philippe Phan, Sean D Christie, Charles G Fisher, Christopher Small, Alex Soroceanu, Christopher S Bailey, Kenneth Thomas, Neil Manson, Greg McIntosh, Zhi Wang, Jay Toor, R Andrew Glennie, Raphaële Charest-Morin
<p><strong>Background context: </strong>While abundant literature supports the clinical benefits of surgery for degenerative cervical myelopathy (DCM), limited evidence exists regarding the extent to which patients' preoperative expectations are met postoperatively.</p><p><strong>Purpose: </strong>This study primarily aimed to report the fulfillment of preoperative expectations 12 months postsurgery. Secondary objectives included identifying predictors of expectation fulfillment and overall patient satisfaction following surgical intervention for DCM.</p><p><strong>Study design/setting: </strong>We conducted a multicenter analysis of spine surgery patients enrolled in the Canadian Spine Outcomes and Research Network (CSORN)-DCM prospective cohort.</p><p><strong>Patient sample: </strong>Patients who underwent surgical treatment for DCM between April 2015 and September 2022 were included.</p><p><strong>Outcome measures: </strong>Patients completed a preoperative 11-domain expectation questionnaire, quantifying their expected clinical changes in each domain. At 12 months postoperatively, patients reported the extent to which their preoperative expectations were met in each domain, as well as their overall satisfaction with surgical outcomes.</p><p><strong>Methods: </strong>Multivariable logistic regression models were employed to identify and validate variables associated with expectation fulfillment and satisfaction.</p><p><strong>Results: </strong>Among the 490 patients included, 49.2% had all their expectations met and 3.7% had none of their expectations met. The expectations that were most frequently met were prevention of neurological decline (87.5%) and maintaining of independence (86.7%). There were 83% of patients who were satisfied at 12 months. Multivariable logistic regression identified preoperative variables (not smoking, not using pain medication presurgery, having lower levels of depressive symptoms (PHQ-8)), surgical variables (anterior and posterior nonfusion approaches), the absence of peri‑operative adverse events and improvement in pain and Health-Related Quality of life scores at 12 months (NRS neck-pain, SF12 PCS and SF-12 MCS scores) as predictors of expectation fulfillment. Improvement in the mJOA score was not a predictor of expectation fulfillment. Having preoperative expectations met was a strong predictor of being satisfied with the surgery (p<.01).</p><p><strong>Conclusions: </strong>The majority of patients undergoing surgery for degenerative cervical myelopathy (DCM) reported satisfaction with their outcomes, with nearly half experiencing complete fulfillment of their preoperative expectations. Importantly, we identified 9 independent predictors of expectation fulfillment, which in turn emerged as a strong determinant of overall patient satisfaction. These findings highlight the critical role of personalized preoperative counseling in optimizing surgical outcomes. By aligning patients' expectations with realistic goals
背景背景:虽然大量文献支持手术治疗退行性颈椎病(DCM)的临床益处,但关于患者术前期望在多大程度上满足术后期望的证据有限。目的:本研究的主要目的是报告术后12个月的术前预期。次要目标包括确定DCM手术干预后预期实现和总体患者满意度的预测因素。研究设计/背景:我们对加入加拿大脊柱结局与研究网络(CSORN)-DCM前瞻性队列的脊柱手术患者进行了多中心分析。患者样本:纳入2015年4月至2022年9月期间接受DCM手术治疗的患者。结果测量:患者完成术前11个领域的期望问卷,量化他们在每个领域的预期临床变化。在术后12个月,患者报告了他们术前在各个领域的期望达到的程度,以及他们对手术结果的总体满意度。方法:采用多变量logistic回归模型识别和验证与期望实现和满意度相关的变量。结果:纳入的490例患者中,49.2%的患者达到了所有预期,3.7%的患者没有达到任何预期。最常满足的期望是预防神经功能衰退(87.5%)和维持独立性(86.7%)。有83%的患者在12个月时感到满意。多变量logistic回归确定了术前变量(不吸烟、术前未使用止痛药、抑郁症状水平较低(PHQ-8))、手术变量(前路和后路非融合入路)、围手术期不良事件的缺失、疼痛和12个月健康相关生活质量评分的改善(NRS颈部疼痛、SF12 PCS和SF-12 MCS评分)作为期望实现的预测因子。mJOA分数的提高并不能预测期望的实现。满足术前预期是手术满意度的重要预测因子(p < 0.01)。结论:大多数接受退行性颈椎病(DCM)手术的患者报告对其结果满意,近一半的患者完全达到了术前预期。重要的是,我们确定了九个期望实现的独立预测因素,这反过来又成为患者总体满意度的重要决定因素。这些发现强调了个性化术前咨询在优化手术结果中的关键作用。通过个性化的护理策略使患者的期望与现实目标保持一致,临床医生可以显著提高患者满意度和DCM手术干预的感知价值。
{"title":"Fulfillment of patient expectations after surgery for degenerative cervical myelopathy. A retrospective analysis of prospectively collected data from the multicenter Canadian Surgical Spine Registry (CSORN).","authors":"Julien Francisco Zaldivar-Jolissaint, Nathan Evaniew, Nicolas Dea, W Bradley Jacobs, Jérome Paquet, Jefferson R Wilson, Hamilton Hall, Supriya Singh, Michael H Weber, Andrew Nataraj, Najmedden Attabib, David W Cadotte, Y Raja Rampersaud, Philippe Phan, Sean D Christie, Charles G Fisher, Christopher Small, Alex Soroceanu, Christopher S Bailey, Kenneth Thomas, Neil Manson, Greg McIntosh, Zhi Wang, Jay Toor, R Andrew Glennie, Raphaële Charest-Morin","doi":"10.1016/j.spinee.2025.11.001","DOIUrl":"10.1016/j.spinee.2025.11.001","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background context: &lt;/strong&gt;While abundant literature supports the clinical benefits of surgery for degenerative cervical myelopathy (DCM), limited evidence exists regarding the extent to which patients' preoperative expectations are met postoperatively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Purpose: &lt;/strong&gt;This study primarily aimed to report the fulfillment of preoperative expectations 12 months postsurgery. Secondary objectives included identifying predictors of expectation fulfillment and overall patient satisfaction following surgical intervention for DCM.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design/setting: &lt;/strong&gt;We conducted a multicenter analysis of spine surgery patients enrolled in the Canadian Spine Outcomes and Research Network (CSORN)-DCM prospective cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patient sample: &lt;/strong&gt;Patients who underwent surgical treatment for DCM between April 2015 and September 2022 were included.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Outcome measures: &lt;/strong&gt;Patients completed a preoperative 11-domain expectation questionnaire, quantifying their expected clinical changes in each domain. At 12 months postoperatively, patients reported the extent to which their preoperative expectations were met in each domain, as well as their overall satisfaction with surgical outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Multivariable logistic regression models were employed to identify and validate variables associated with expectation fulfillment and satisfaction.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among the 490 patients included, 49.2% had all their expectations met and 3.7% had none of their expectations met. The expectations that were most frequently met were prevention of neurological decline (87.5%) and maintaining of independence (86.7%). There were 83% of patients who were satisfied at 12 months. Multivariable logistic regression identified preoperative variables (not smoking, not using pain medication presurgery, having lower levels of depressive symptoms (PHQ-8)), surgical variables (anterior and posterior nonfusion approaches), the absence of peri‑operative adverse events and improvement in pain and Health-Related Quality of life scores at 12 months (NRS neck-pain, SF12 PCS and SF-12 MCS scores) as predictors of expectation fulfillment. Improvement in the mJOA score was not a predictor of expectation fulfillment. Having preoperative expectations met was a strong predictor of being satisfied with the surgery (p&lt;.01).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The majority of patients undergoing surgery for degenerative cervical myelopathy (DCM) reported satisfaction with their outcomes, with nearly half experiencing complete fulfillment of their preoperative expectations. Importantly, we identified 9 independent predictors of expectation fulfillment, which in turn emerged as a strong determinant of overall patient satisfaction. These findings highlight the critical role of personalized preoperative counseling in optimizing surgical outcomes. By aligning patients' expectations with realistic goals","PeriodicalId":49484,"journal":{"name":"Spine Journal","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2025-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Spine Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1